Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Colombia


MONTREAL, Sept. 01, 2026 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (“Knight”) (TSX: GUD), a pan-American (ex-US) pharmaceutical company, announced today that it has received regulatory approval from INVIMA, the Colombian health regulatory agency, for TAVALISSE® (fostamatinib disodium hexahydrate) for the treatment of adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response, loss of response, or intolerance to prior treatment with corticosteroids and intravenous immunoglobulin.1



Source link

  • Related Posts

    Human errors cause B.C. to overshoot gas revenues by $1.5B

    Four spreadsheet and conversion errors in B.C.’s latest budget led to a $1.5-B overestimation of gas revenues, officials say The B.C. government made four human-caused administrative errors leading to a…

    Canadian Salsa Festivals Project Tour Expands with the Inaugural Salsa at Niagara Falls September 12-13 │ Noon – 10P with Nightly Fireworks

    About Fallsview Casino ResortOverlooking the world-famous Horseshoe Falls, Fallsview Casino Resort is an award-winning resort that has been offering premier entertainment and superior guest service since 2004. Featuring a hotel…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Metal Gear Solid: Master Collection Vol. 2 Review (Switch 2)

    Metal Gear Solid: Master Collection Vol. 2 Review (Switch 2)

    Beloved dad of 4 who was killed by lightning stopped to help boater, cousin says

    Beloved dad of 4 who was killed by lightning stopped to help boater, cousin says

    Apple follows Google in adopting Trump’s ‘Lake America’ name

    Apple follows Google in adopting Trump’s ‘Lake America’ name

    5 Aircraft That Got Remarkably Close To Service Before Their Programs Collapsed

    5 Aircraft That Got Remarkably Close To Service Before Their Programs Collapsed

    Minister Hussen to make an announcement in support of small-scale financial institutions in developing countries

    Human errors cause B.C. to overshoot gas revenues by $1.5B

    Human errors cause B.C. to overshoot gas revenues by $1.5B